Skip to main content
. Author manuscript; available in PMC: 2016 May 15.
Published in final edited form as: Int J Pharm. 2015 Feb 24;485(0):7–14. doi: 10.1016/j.ijpharm.2015.02.059

Figure 2.

Figure 2

In vitro cumulative release of Cy7 drug from different silk fibroin-Cy7 (SF-Cy7) microparticle formulations. A two-factor analysis of variance was used to determine statistical differences between formulations at each time point. * = p<0.05 for SF-Cy733% vs. SF-Cy7100% and SF-Cy750%; # = p<0.05: SF-Cy733% vs. SF-Cy7100%; †=p<0.05: SF-Cy750% vs. SF-Cy7100%.